BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34661888)

  • 1. Human Papillomavirus-Associated Cancers.
    Alhamlan FS; Alfageeh MB; Al Mushait MA; Al-Badawi IA; Al-Ahdal MN
    Adv Exp Med Biol; 2021; 1313():1-14. PubMed ID: 34661888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
    Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
    Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
    Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
    JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic burden of HPV-related cancers in the US veteran population.
    Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N
    J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
    Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
    Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
    Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
    Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and Screening of HPV Malignancies.
    Dahlstrom KR; Day AT; Sturgis EM
    Semin Radiat Oncol; 2021 Oct; 31(4):297-308. PubMed ID: 34455985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of human papillomaviruses in cancers of different human organ sites.
    Shukla S; Bharti AC; Mahata S; Hussain S; Kumar R; Hedau S; Das BC
    Indian J Med Res; 2009 Sep; 130(3):222-33. PubMed ID: 19901431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
    J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
    Gillison ML; Chaturvedi AK; Lowy DR
    Cancer; 2008 Nov; 113(10 Suppl):3036-46. PubMed ID: 18980286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.
    Giuliano AR; Nyitray AG; Kreimer AR; Pierce Campbell CM; Goodman MT; Sudenga SL; Monsonego J; Franceschi S
    Int J Cancer; 2015 Jun; 136(12):2752-60. PubMed ID: 25043222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G
    Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications and efficacy of the human papillomavirus vaccine.
    Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
    Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.
    Otter S; Whitaker S; Chatterjee J; Stewart A
    Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):81-90. PubMed ID: 30385006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E; Largeron N
    J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.